“fda” Archives

in
Entry Author Date Location
Cancer Drugmaker G1 Therapeutics Makes IPO Pitch To Wall Street 04/17/17 Raleigh Durham
FDA Nixes Lilly, Incyte RA Drug, Seeks More Dosing and Safety Data 04/14/17 Indiana
Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More 04/14/17 National
Tocagen IPO Raises $85M to Test Gene Therapy in Brain Cancer Trials 04/13/17 San Diego
Lyndra’s Long-Acting Drug Delivery Technology Lands $23M Investment 04/13/17 Boston
Emulate’s “Organ-on-a-Chip” Tech Picked for FDA Research Partnership 04/11/17 Boston
Lucigen, EnsoData, Rowheels, & More: This Week’s Wisconsin Watchlist 04/07/17 Wisconsin
FDA OKs 23andMe’s Direct-to-Consumer Genetic Tests, With Caution 04/06/17 San Francisco
Gedeon Richter Gets Ex-U.S. Rights for Evestra Urological Product 04/06/17 Texas
Zavante Plans FDA Filing After Antibiotic Hits Clinical Trial Goals 04/06/17 San Diego
FDA Nominee Scott Gottlieb To Anti-Vaccine Crowd: Get Over It 04/05/17 National
Cydan, NEA’s Orphan Drug Experiment, Pays Off in $200M Vtesse Deal 04/03/17 Boston
New Blood: Biotech CEOs Bring Fresh Experience to Houston Ecosystem 04/03/17 Texas
Bio Roundup: New Drug Bonanza, Vertex’s Triple Play, CAR-T Race & More 03/31/17 National
Boston Scientific to Acquire Heart Device Maker Symetis for $435M 03/30/17 Boston
Third Rock’s Tango Aims For Drugs That Turn Cancer Against Itself 03/30/17 Boston
With FDA Approval, Genentech Drug Becomes First For Severe MS Cases 03/29/17 San Francisco
With New Data, Vertex Touts Backbone Of Future Cystic Fibrosis Drugs 03/28/17 Boston
FDA OKs Eczema Injection; Owners Regeneron, Sanofi Set $37K Price 03/28/17 New York
Tesaro’s Ovarian Cancer Drug Gets FDA Nod, No Diagnostic Needed 03/27/17 Boston
After $1M NEI Grant, ONL Therapeutics Closer to Clinical Trials 03/27/17 Detroit Ann Arbor
Ionis Pharma Spins Out Lipid Disorder Unit Akcea with Plans for IPO 03/27/17 Boston
Texas Roundup: SXSW Odds & Ends, Dosh, Mythic, Peloton, & More 03/22/17 Texas
BioClin Gets $30M to Back More Bladder Cancer Drug Trials 03/22/17 San Francisco
SutroVax Lands $64M From Roche, Others to Back Vaccine Studies 03/21/17 San Francisco
No Pain, No High: Nektar’s Opioid Drug Hits Trial Goals, Lifts Shares 03/20/17 San Francisco
For $140M, PTC Gets Duchenne Drug and a Pricing Controversy from Marathon 03/16/17 New York
Proteon Therapeutics Plans Path Forward for Blood Vessel Drug 03/16/17 Boston
With FDA’s Blessing, Seres Preps New “Pivotal” Microbiome Drug Trial 03/16/17 Boston
Myomo, a Robotic Arm Brace Maker, Aims to Raise $15M in “Mini-IPO” 03/15/17 Boston
Page 3 of 61 « previous page · next page »